The Institute of Applied Research (Invap) signed a Strategic Cooperation Agreement with the Chinese companies Jianxi Nuclear Power (JXNPC) and Shanghai Nuclear Engineering Research & Design Institute (SNARDI) for the export of reactors and the production of medicinal isotopes.
The agreement was signed in a virtual meeting in which the ambassadors of Argentina in Beijing, Sabino Vaca Narvaja, and China in Buenos Aires, Zhou Xiaoli, participated.
As reported, It is an agreement framed in the agreements signed by President Alberto Fernandez in the last visit in February of this year, they highlighted from the Argentine Embassy.
In this regard, Vaca Narvaja said that “this agreement is an important milestone for our relationship, since in this case Argentina is the one that transfers technology to China”, and added that “Argentina is a great producer of innovative technologies and developments”.
“Argentine companies such as Nucleoeléctrica Argentina, Invap, Arsat, YPF, Conae, INTI, Impsa, Nuclearis, SpaceSUR are cooperating with Chinese counterparts on different scientific-technological projects,” the ambassador added.
For his part, the Chinese ambassador, Zhou Xiaoli, highlighted his country’s interest in “increasing cooperation in the area of technology transfer in the bilateral relationship.”
“We are working to build a long-term virtuous relationship that allows the development of both countries,” Xiaoli stated.
Meanwhile, the deputy manager of Marketing of the nuclear area of Invap, Pablo Abbate, sustained the Chinese agency Xinhua that “it is a pride that they have chosen us to work on a project for the health of the Chinese population”.
In addition, Abbate explained that the specific use of these reactors is “so that certain materials placed inside the reactor become useful radioactive material for nuclear medicine that allow different types of cancer studies, tumors, melanomas, studies of blood irrigation, thyroid, and different types of diagnosis that allow improving and lengthening the quality of life of different patients”.
To advance the agreement, the Chinese company Jiangxi has already reserved a space for the construction of two reactors next to Invap, which was visited by Vaca Narvaja, located in the Isotope Research Center, belonging to the city of Jiujiang, east from China.
